Filing Details
- Accession Number:
- 0001181431-13-063318
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 12:49:36
- Reporting Period:
- 2013-12-18
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 12:49:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
822411 | Immunocellular Therapeutics Ltd. | IMUC | Pharmaceutical Preparations (2834) | 931301885 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563623 | Andrew Gengos | 23622 Calabasas Road, Suite 300 Calabasas CA 91302 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-18 | 27,000 | $0.72 | 27,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6999 to $0.7200.